Human Anti-SIRPA Recombinant Antibody scFv Fragment (PABJ-0084-S(P))

CAT#: PABJ-0084-S(P)

This product is a Human antibody scFv fragment that recognizes Human SIRPA. This antibody is specific for human and cynomolgus monkey SIRPα. PABJ-0084-S(P) potently antagonizes the SIRPα/CD47 interaction.

Gene Expression
Figure 1 Cerebral cortex Figure 2 Colon Figure 3 Lymph node Figure 4 RNA cell line category: Cell line enhanced (fHDF/TERT166, RPTEC TERT1, SK-MEL-30)

Specifications

  • Host Species
  • Human
  • Type
  • Human scFv
  • Specificity
  • Human SIRPA
  • Species Reactivity
  • Human, Monkey
  • Applications
  • ELISA, Block

Product Property

  • Purification
  • Purified
  • Purity
  • >95% as determined by SDS-PAGE and HPLC analysis
  • Buffer
  • PBS
  • Storage
  • Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Applications

  • Application Notes
  • This antibody has been reported for use in Enzyme-linked Immunosorbent Assay, Blocking.

Target

  • Alternative Names
  • BIT; MFR; P84; SIRP; MYD-1; SHPS1; CD172A; PTPNS1; tyrosine-protein phosphatase non-receptor type substrate 1; CD172 antigen-like family member A; brain-immunoglobulin-like molecule with tyrosine-based activation motifs; inhibitory receptor SHPS-1; macrophage fusion receptor; myd-1 antigen; tyrosine phosphatase SHP substrate 1
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for PABJ-0084-S(P). Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Ideal for Blocking Assays
We've successfully employed this scFv fragment in blocking assays, where it consistently disrupts the SIRPA/CD47 interaction. This property is pivotal in unveiling immune escape mechanisms, making it invaluable for our study of cancer immunotherapies.
Breast cancer biomarkers at key points during disease progression
Reliable and Specific
The high specificity of this antibody fragment has streamlined our ELISA protocols, providing reliable results with minimal interference. It has become a cornerstone in our assays, allowing for precise protein quantification.
Breast cancer biomarkers at key points during disease progression
Exceptional Versatility
Its versatility in applications ranging from ELISA to blocking experiments has greatly benefited our lab. This flexibility supports a wide array of research focuses, from oncology to autoimmune disease studies.

Q&As

  1. What is the primary application of the Human Anti-SIRPA scFv Fragment?

    A: The Human Anti-SIRPA scFv Fragment is prominently used in enzyme-linked immunosorbent assays (ELISA) and blocking applications. This makes it an essential tool for researching the SIRPA/CD47 interaction, especially in immune response studies and cancer.

  2. What specific targets does this antibody fragment bind to?

    A: The antibody fragment binds specifically to the SIRPα protein on myeloid cells and recognizes both human and cynomolgus monkey proteins. This specificity is vital for research involving these species, facilitating preclinical model studies.

  3. How does the scFv format enhance its research utility?

    A: The small size of the scFv format allows for better tissue penetration and accessibility to hidden epitopes, making it highly effective for both in vitro and in vivo applications.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "Sirpa"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
NAB-1201-VHH Recombinant Anti-Mouse Sirpa VHH Single Domain Antibody IP, FC, ChiP, Neut Llama VHH
CAT Product Name Application Type
BRD-0465MZ Chicken Anti-PTPNS1 Polyclonal IgY WB Chicken antibody
CAT Product Name Application Type
NEUT-1970CQ Recombinant Rat Anti-Sirpa Antibody (P84) FC, BL, IF, IHC, IP IgG1, κ
CAT Product Name Application Type
NEUT-1971CQ Recombinant Mouse Anti-Sirpa Antibody (CBL650) WB, FC, CyTOF, Neut IgG2b
CAT Product Name Application Type
VS-0724-YC1462 AbPlus™ Anti-SIRPA Magnetic Beads (VS-0724-YC1462) IP, Protein Purification
CAT Product Name Application Type
VS-0325-FY86 Human Anti-SIRPA (clone 29-AM3-35) scFv-Fc Chimera ELISA, Inhib Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC143 Recombinant Anti-SIRPA Vesicular Antibody, EV Displayed (VS-0425-YC143) Cyt, ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare